Our 87,000 sq. ft. cGMP-certified drug product manufacturing facility, located in Baltimore, Maryland, offers aseptic fill/finish manufacturing of biologics and sterile injectables.
As biopharma complexity grows, flexible CDMOs like Afton Scientific are essential for navigating fill/finish needs, accelerated timelines, and regulatory uncertainty with agility and expertise.
Explore how Catalent's proven expertise and simplified execution with development, filling, and analytical under one roof ensure safe, efficacious products reach patients in need.
Equipped with advanced isolator and RABs technologies, our aseptic filling facilities feature multiple filling lines capable of producing liquid and lyophilized vials as well as prefilled syringes.
Discover how Curia's sterile fill/finish expertise, high-potency capabilities, and customizable cleanrooms can support your product from development to commercialization.
Learn how delivering a comprehensive CMC package under a single manufacturer can help to minimize the complexity of multiple vendors that leads to major risks for RNA program success.
Learn why adherence to sterile conditions is an essential step in development and manufacturing to guarantee the safety, efficacy, quality, and regulatory compliance of pharmaceutical products.
Equipped with advanced robotics, Argonaut's automated fill line is specially designed to maximize product yield while minimizing the risks associated with operator intervention.
